Skip to main content

Imaging of Interventional Therapies in Oncology: Ultrasound

  • Reference work entry
  • First Online:
Image-Guided Cancer Therapy
  • 1468 Accesses

Abstract

Ultrasonography (US) and contrast-enhanced ultrasonography (CEUS) play a key role at each step of imaging-guided therapies. Ultrasound (US) is actually the most widely diffused imaging technique for the guidance of percutaneous ablation as it allows for real-time visualization of the ablation device insertion and monitoring of the procedure and does not require ionizing radiation.

CEUS allows to diagnose focal lesions on the basis of enhancement patterns that are analogous to those typically seen on contrast-enhanced CT and MRI. Compared to CT and MRI, CEUS has the limitation to enable the study of one lesion at a time, but it has the advantage to be a real-time technique. CEUS is usefully employed before ablation for detection and characterization of lesions, pre-procedure planning, intra-procedure targeting (particularly for difficult and/or small lesions) and monitoring and, immediately after ablation, correct assessment of the volume of necrosis achieved, and detection of possible residual foci of untreated tumor.

CEUS can also implement B-mode US when real-time US-CT/MRI fusion imaging (or “virtual navigation”) is employed: Real-time US is co-registered with previously acquired contrast-enhanced CT or MRI scans multiplanarly reconstructed and transferred to the US machine.

In conclusion, for interventional therapies of lesions and organs that can be imaged with US, CEUS is a very valuable tool in all the phases of treatments. When follow-up contrast-enhanced CT or MRI are contraindicated or not conclusive, CEUS can also be used in follow-up protocols.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 269.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Solomon SB, Silverman SG. Imaging in interventional oncology. Radiology. 2010;257:624–40.

    Article  PubMed  Google Scholar 

  2. Wiering B, Ruers TJ, Krabbe PF, Dekker HM, Oyen WJ. Comparison of multiphase CT, FDG-PET and intra-operative ultrasound in patients with colorectal liver metastases selected for surgery. Ann Surg Oncol. 2007;14(2):818–26.

    Article  CAS  PubMed  Google Scholar 

  3. Harvey CJ, Albrecht T. Ultrasound of focal liver lesions. Eur Radiol. 2001;11:1578–93.

    Article  CAS  PubMed  Google Scholar 

  4. Solbiati L, Tonolini M, Cova L, Goldberg SN. The role of contrast-enhanced ultrasound in the detection of focal liver lesions. Eur Radiol. 2001;11 Suppl 3:E15–26.

    Article  PubMed  Google Scholar 

  5. Lencioni R, Cioni D, Bartolozzi C. Tissue harmonic and contrast-specific imaging: back to gray scale in ultrasound. Eur Radiol. 2002;12:151–65.

    Article  PubMed  Google Scholar 

  6. Maruyama H, Takahashi M, Ishibashi H, et al. Ultrasound-guided treatments under low acoustic power contrast harmonic imaging for hepatocellular carcinomas undetected by B-mode ultrasonography. Liver Int. 2009;29:708–14.

    Article  PubMed  Google Scholar 

  7. Minami Y, Kudo M, Chung H, et al. Contrast harmonic sonography-guided radiofrequency ablation therapy versus B-mode sonography in hepatocellular carcinoma: prospective randomized controlled trial. AJR Am J Roentgenol. 2007;188:489–94.

    Article  PubMed  Google Scholar 

  8. Numata K, Morimoto M, Ogura T, et al. Ablation therapy guided by contrast-enhanced sonography with Sonazoid for hepatocellular carcinoma lesions not detected by conventional sonography. J Ultrasound Med. 2008;27:395–406.

    Article  PubMed  Google Scholar 

  9. Chen MH, Wu W, Yang W, et al. The use of contrast-enhanced ultrasonography in the selection of patients with hepatocellular carcinoma for radiofrequency ablation therapy. J Ultrasound Med. 2007;26:1055–63.

    Article  PubMed  Google Scholar 

  10. Chen MH, Yang W, Yan K, et al. The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation. Clin Radiol. 2007;62:752–60.

    Article  CAS  PubMed  Google Scholar 

  11. Luo W, Numata K, Morimoto M, et al. Clinical utility of contrast-enhanced three-dimensional ultrasound imaging with Sonazoid: findings on hepatocellular carcinoma lesions. Eur J Radiol. 2009;72:425–31.

    Article  PubMed  Google Scholar 

  12. Hakime A, Deschamps F, De Carvalho EG, Teriitehau C, Auperin A, De Baere T. Clinical evaluation of spatial accuracy of a fusion imaging technique combining previously acquired computed tomography and real-time ultrasound for imaging of liver metastases. Cardiovasc Intervent Radiol. 2011;34(2):338–44.

    Article  PubMed  Google Scholar 

  13. Kawasoe H, Eguchi Y, Mizuta T, et al. Radiofrequency ablation with real-time virtual sonography system for treating hepatocellular carcinoma difficult to detect by ultrasonography. J Clin Biochem Nutr. 2007;40(1):66–72.

    Article  PubMed  Google Scholar 

  14. Liu FY, Yu XL, Liang P, et al. Microwave ablation assisted by a real-time virtual navigation system for hepatocellular carcinoma undetectable by conventional ultrasonography. Eur J Radiol. 2012;81(7):1455–9.

    Article  PubMed  Google Scholar 

  15. Minami Y, Chung H, Kudo M. Radiofrequency ablation of hepatocellular carcinoma: value of virtual CT sonography with magnetic navigation. AJR Am J Roentgenol. 2008;190(6):335–41.

    Article  Google Scholar 

  16. Wood BJ, Kruecker J, Abi-Jaoudeh N, et al. Navigation systems for ablation. J Vasc Interv Radiol. 2010;21(8 Suppl):S257–63.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Claudon M, Cosgrove D, Albrecht T, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) – update 2008. Ultraschall Med. 2008;29:28–44.

    Article  CAS  PubMed  Google Scholar 

  18. Solbiati L, Tonolini M, Cova L. Monitoring RF ablation. Eur Radiol. 2004;14 Suppl 8:P34–42.

    PubMed  Google Scholar 

  19. Rhim H, Goldberg SN, Dodd GD, Solbiati L, Lim HK, Tonolini M, Cho OK. Essential techniques for successful radiofrequency thermal ablation of malignant hepatic tumors. Radiographics. 2001;21:S17–31.

    Article  PubMed  Google Scholar 

  20. Andreana L, Kudo M, Hanataka K, et al. Contrast-enhanced ultrasound techniques for guiding and assessing response to locoregional treatments for hepatocellular carcinoma. Oncology. 2010;78 Suppl 1:68–77.

    Article  PubMed  Google Scholar 

  21. Kim HJ, Kim TK, Kim PN, et al. Assessment of the therapeutic response of hepatocellular carcinoma treated with transcatheter arterial chemoembolization. Comparison of contrast-enhanced sonography and 3-phase computed tomography. J Ultrasound Med. 2006;25:477–86.

    Article  PubMed  Google Scholar 

  22. Miyamoto N, Hiramatsu K, Tsuchiya K, et al. Contrast-enhanced sonography-guided radiofrequency ablation for the local recurrence of previously treated hepatocellular carcinoma undetected by B-mode sonography. J Clin Ultrasound. 2010;38:339–45.

    PubMed  Google Scholar 

  23. Ricci P, Cantisani V, Drudi F, et al. Is contrast-enhanced US alternative to spiral CT in the assessment of treatment outcome of radiofrequency ablation in hepatocellular carcinoma? Ultraschall Med. 2009;30:252–8.

    Article  CAS  PubMed  Google Scholar 

  24. Shiozawa K, Watanabe M, Takayama R, et al. Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography. J Clin Ultrasound. 2010;38:182–9.

    PubMed  Google Scholar 

  25. Vilana R, Bianchi L, Varela M, BCLC Group, et al. Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma? Eur Radiol. 2006;16:2454–62.

    Article  CAS  PubMed  Google Scholar 

  26. Kisaka Y, Hirooka M, Koizumi Y, et al. Contrast-enhanced sonography with abdominal virtual sonography in monitoring radiofrequency ablation of hepatocellular carcinoma. J Clin Ultrasound. 2010;38:138–44.

    PubMed  Google Scholar 

  27. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205–16.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Luigi Solbiati .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this entry

Cite this entry

Solbiati, L., Tondolo, T. (2013). Imaging of Interventional Therapies in Oncology: Ultrasound. In: Dupuy, D., Fong, Y., McMullen, W. (eds) Image-Guided Cancer Therapy. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0751-6_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-0751-6_15

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-0750-9

  • Online ISBN: 978-1-4419-0751-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics